BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28353089)

  • 1. Histological, immunohistological and molecular characteristics of intraductal precursor of carcinoma ex pleomorphic adenoma support a multistep carcinogenic process.
    Ihrler S; Guntinas-Lichius O; Agaimy A; Wolf A; Mollenhauer M
    Virchows Arch; 2017 Jun; 470(6):601-609. PubMed ID: 28353089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraductal carcinoma is the precursor of carcinoma ex pleomorphic adenoma and is often associated with dysfunctional p53.
    Ihrler S; Weiler C; Hirschmann A; Sendelhofert A; Lang S; Guntinas-Lichius O; Arnold G; Zietz C; Harrison JD
    Histopathology; 2007 Sep; 51(3):362-71. PubMed ID: 17593217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoma ex pleomorphic adenoma with special reference to the prognostic significance of histological progression: a clinicopathological investigation of 41 cases.
    Weiler C; Zengel P; van der Wal JE; Guntinas-Lichius O; Schwarz S; Harrison JD; Kirchner T; Ihrler S
    Histopathology; 2011 Oct; 59(4):741-50. PubMed ID: 22014054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER-2/neu and MIB1 immunohistochemistry.
    Di Palma S; Skálová A; Vanìèek T; Simpson RH; Stárek I; Leivo I
    Histopathology; 2005 Feb; 46(2):144-52. PubMed ID: 15693886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100P expression in ductal type of carcinoma ex pleomorphic adenoma.
    Hashimoto K; Yamamoto H; Shiratsuchi H; Nakashima T; Tamiya S; Higaki Y; Komune S; Tsuneyoshi M; Oda Y
    Am J Surg Pathol; 2011 Mar; 35(3):346-55. PubMed ID: 21317706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER-2/neu gene amplification in carcinoma ex pleomorphic adenoma in relation to progression and prognosis: a chromogenic in-situ hybridization study.
    Hashimoto K; Yamamoto H; Shiratsuchi H; Nakashima T; Tamiya S; Nishiyama K; Higaki Y; Komune S; Tsuneyoshi M; Oda Y
    Histopathology; 2012 May; 60(6B):E131-42. PubMed ID: 22486195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions.
    Bahrami A; Perez-Ordonez B; Dalton JD; Weinreb I
    Histopathology; 2013 Aug; 63(2):250-62. PubMed ID: 23738717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoma ex pleomorphic adenoma of the salivary gland: an immunohistochemical study.
    Matsubayashi S; Yoshihara T
    Eur Arch Otorhinolaryngol; 2007 Jul; 264(7):789-95. PubMed ID: 17310348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary carcinosarcoma: insight into multistep pathogenesis indicates uniform origin as sarcomatoid variant of carcinoma ex pleomorphic adenoma with frequent heterologous elements.
    Ihrler S; Stiefel D; Jurmeister P; Sandison A; Chaston N; Laco J; Zidar N; Brcic L; Stoehr R; Agaimy A
    Histopathology; 2023 Mar; 82(4):576-586. PubMed ID: 36376255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pleomorphic adenoma: pitfalls and clinicopathological forms of progression].
    Ihrler S; Schwarz S; Zengel P; Guntinas-Lichius O; Kirchner T; Weiler C
    Pathologe; 2009 Nov; 30(6):446-56. PubMed ID: 19844715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts.
    Katabi N; Ghossein R; Ho A; Dogan S; Zhang L; Sung YS; Antonescu CR
    Hum Pathol; 2015 Jan; 46(1):26-33. PubMed ID: 25439740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma.
    de Brito BS; Giovanelli N; Egal ES; Sánchez-Romero C; Nascimento JS; Martins AS; Tincani ÁJ; Del Negro A; Gondak RO; Almeida OP; Kowalski LP; Altemani A; Mariano FV
    Hum Pathol; 2016 Nov; 57():152-159. PubMed ID: 27473265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors of recurrence in salivary carcinoma ex pleomorphic adenoma, with emphasis on the carcinoma histologic subtype: a clinicopathologic study of 43 cases.
    Katabi N; Gomez D; Klimstra DS; Carlson DL; Lee N; Ghossein R
    Hum Pathol; 2010 Jul; 41(7):927-34. PubMed ID: 20338616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular Proliferation Index between Carcinoma Ex-Pleomorphic Adenoma and Pleomorphic Adenoma.
    Mariano FV; Costa AF; Gondak RO; Martins AS; Del Negro A; Tincani ÁJ; Altemani A; de Almeida OP; Kowalski LP
    Braz Dent J; 2015; 26(4):416-21. PubMed ID: 26312983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased SOX2 expression in salivary gland carcinoma ex pleomorphic adenoma progression: an association with adverse outcome.
    Sedassari BT; Rodrigues MFSD; Conceição TS; Mariano FV; Alves VAF; Nunes FD; Altemani A; de Sousa SCOM
    Virchows Arch; 2017 Dec; 471(6):775-784. PubMed ID: 28842747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoma ex pleomorphic adenoma of the salivary glands: distinct clinicopathologic features and immunoprofiles between subgroups according to cellular differentiation.
    Kim JW; Kwon GY; Roh JL; Choi SH; Nam SY; Kim SY; Cho KJ
    J Korean Med Sci; 2011 Oct; 26(10):1277-85. PubMed ID: 22022178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary duct carcinoma and the concept of early carcinoma ex pleomorphic adenoma.
    Griffith CC; Thompson LD; Assaad A; Purgina BM; Lai C; Bauman JE; Weinreb I; Seethala RR; Chiosea SI
    Histopathology; 2014 Dec; 65(6):854-60. PubMed ID: 24804831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoma ex pleomorphic adenoma of the buccal region is composed of salivary duct carcinoma and squamous cell carcinoma components.
    Nakamori K; Ohuchi T; Hasegawa T; Hiratsuka H
    Int J Oral Maxillofac Surg; 2009 Oct; 38(10):1116-8. PubMed ID: 19467841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoma ex pleomorphic adenoma, with particular emphasis on early lesions.
    Di Palma S
    Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S68-76. PubMed ID: 23821206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoprofile of reactive salivary myoepithelial cells in intraductal areas of carcinoma ex-pleomorphic adenoma.
    de Araújo VC; Altemani A; Furuse C; Martins MT; de Araújo NS
    Oral Oncol; 2006 Nov; 42(10):1011-6. PubMed ID: 16757205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.